Literature DB >> 7838385

Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems.

T J Collier1, J D Elsworth, J R Taylor, J R Sladek, R H Roth, D E Redmond.   

Abstract

Previous studies of rats in our laboratory indicate that a molecule or molecules released by Schwann cells exert survival and growth-promoting effects on mesencephalic dopamine neurons. In the present study, we have begun to investigate the potential for Schwann cell augmentation of host dopamine fiber systems and embryonic dopamine neuron grafts in non-human primates. Ten adult male St Kitts African Green monkeys treated with the dopaminergic neurotoxin 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine one year previously, but behaviorally asymptomatic, served as hosts for implant studies. A segment of young adult monkey saphenous nerve was collected to serve as an implanted tissue source of Schwann cell-derived growth factors. Nerve was enclosed in a hollow semi-permeable polymer fiber for implantation into the lateral ventricle, with embryonic ventral mesencephalic tissue co-grafts containing developing dopamine neurons aimed at nearby locations in the caudate nucleus. Control implants consisted of an empty polymer fiber co-grafted with embryonic ventral mesencephalon. Our morphological observations indicate that while no clear augmentation of the morphology of grafted dopamine neurons attributable to co-grafted nerve was observed, this lack of influence may be related to the spatial separation of the co-grafted tissues. In contrast, some monkeys with nerve segments in the lateral ventricle exhibited increased tyrosine hydroxylase-positive fiber staining in the immediately adjacent lateral septal area and the ventricular wall of the caudate nucleus. This enhancement was not associated with empty polymer implants. Levels of dopamine and its metabolite homovanillic acid derived from tissue punches in the caudate nucleus and septal area support the view that monkeys exhibiting morphological enhancement of host dopamine systems also show biochemical increases in dopamine levels and changes in the direction of normalization of the homovanillic acid/dopamine ratio. Biochemical values from a single septal area tissue punch in one animal were an exception to this rule. This study suggests that while the utility of peripheral nerve as a source of dopamine graft augmentation in non-human primates remains to be demonstrated, grafted nerve has a stimulatory effect on host brain dopamine systems in adult, dopamine-depleted monkeys, and that this morphological effect can be dissociated from previously hypothesized injury-induced regeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838385     DOI: 10.1016/0306-4522(94)90410-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions.

Authors:  C Dirk Keene; Rubens C Chang; James B Leverenz; Oleg Kopyov; Susan Perlman; Robert F Hevner; Donald E Born; Thomas D Bird; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2008-12-05       Impact factor: 17.088

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 3.  Cellular repair in the parkinsonian nonhuman primate brain.

Authors:  Donald Eugene Redmond; Stephanie Weiss; John D Elsworth; Robert H Roth; Dustin R Wakeman; Kimberly B Bjugstad; Timothy J Collier; Barbara C Blanchard; Yang D Teng; Evan Y Synder; John R Sladek
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

Review 4.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 5.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

6.  Using a Transection Paradigm to Enhance the Repair Mechanisms of an Investigational Human Cell Therapy.

Authors:  Monica J Chau; Jorge E Quintero; Paula V Monje; Stephen Randal Voss; Andrew S Welleford; Greg A Gerhardt; Craig G van Horne
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.